☰

Yulia Y. Ovechkina, Ph.D. - Publications

Affiliations: 
2004 University of Washington, Seattle, Seattle, WA 
Area:
Cell Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Wagenbach M, Vicente JJ, Ovechkina Y, Domnitz S, Wordeman L. Functional characterization of MCAK/Kif2C cancer mutations using high-throughput microscopic analysis. Molecular Biology of the Cell. mbcE19090503. PMID 31746663 DOI: 10.1091/Mbc.E19-09-0503  0.648
2019 Washburn A, Abdeen S, Ovechkina Y, Ray AM, Stevens M, Chitre S, Sivinski J, Park Y, Johnson J, Hoang QQ, Chapman E, Parish T, Johnson SM. Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections. Bioorganic & Medicinal Chemistry Letters. PMID 31047750 DOI: 10.1016/J.Bmcl.2019.04.034  0.319
2019 Odingo JO, Early JV, Smith J, Johnson J, Bailey MA, Files M, Guzman J, Ollinger J, Korkegian A, Kumar A, Ovechkina Y, Parish T. 8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis. Drug Development Research. PMID 30893501 DOI: 10.1002/Ddr.21531  0.315
2018 Martinez-Grau MA, Valcarcel ICG, Early JV, Gessner RK, de Melo CS, de la Nava EMM, Korkegian A, Ovechkina Y, Flint L, Gravelle A, Cramer JW, Desai PV, Street LJ, Odingo J, Masquelin T, et al. Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters. PMID 29680666 DOI: 10.1016/J.Bmcl.2018.04.028  0.33
2017 Manning AJ, Ovechkina Y, McGillivray A, Flint L, Roberts DM, Parish T. A high content microscopy assay to determine drug activity against intracellular Mycobacterium tuberculosis. Methods (San Diego, Calif.). PMID 28366666 DOI: 10.1016/J.Ymeth.2017.03.022  0.307
2016 Bonnett SA, Ollinger J, Chandrasekera S, Florio S, O'Malley T, Files M, Jee JA, Ahn J, Casey A, Ovechkina Y, Roberts D, Korkegian A, Parish T. A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase. Acs Infectious Diseases. PMID 27642770 DOI: 10.1021/Acsinfecdis.6B00075  0.307
2016 Kesicki EA, Bailey MA, Ovechkina Y, Early JV, Alling T, Bowman J, Zuniga ES, Dalai S, Kumar N, Masquelin T, Hipskind PA, Odingo JO, Parish T. Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents. Plos One. 11: e0155209. PMID 27171280 DOI: 10.1371/Journal.Pone.0155209  0.317
2015 Chandrasekera NS, Alling T, Bailey MA, Files M, Early JV, Ollinger J, Ovechkina Y, Masquelin T, Desai PV, Cramer JW, Hipskind PA, Odingo JO, Parish T. Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity. Journal of Medicinal Chemistry. 58: 7273-85. PMID 26295286 DOI: 10.1021/Acs.Jmedchem.5B00546  0.327
2015 Chandrasekera NS, Alling T, Bailey M, Korkegian A, Ahn J, Ovechkina Y, Odingo J, Parish T. The 4-aminopiperidine series has limited anti-tubercular and anti-staphylococcus aureus activity. Journal of Negative Results in Biomedicine. 14: 4. PMID 25881065 DOI: 10.1186/S12952-015-0024-X  0.322
2012 Bernards K, Ovechkina Y, Cheng J, Kushleika J, Angione A, Hnilo J, O'Day C. Abstract 2806: BRAF and MEK inhibitor profiling across 240 tumor cell lines to correlate with sensitivity and resistant biomarkers Cancer Research. 72: 2806-2806. DOI: 10.1158/1538-7445.Am2012-2806  0.357
2011 Ovechkina YY, O'Day C, Marcoe K, Keyser R, Bernards K, Chesnut-Speelman J, Nguyen P, Mulligan J, Lin T, Shively R, Hnilo J, Nelson B. Abstract 4845: Tumor cell line profiling of eighteen cancer therapeutics to evaluate relationships between tumor genotypes and cancer cell sensitivities Cancer Research. 71: 4845-4845. DOI: 10.1158/1538-7445.Am2011-4845  0.343
2011 O'Day CL, Ovechkina Y, Marcoe K, Keyser R, Chesnut-Speelman J, Hnilo J. Abstract 239: Biomarker profiling and combination studies of receptor tyrosine kinase inhibitors of EGFR, ERBB2, IGFR-1, FGFR and PDGFR Cancer Research. 71: 239-239. DOI: 10.1158/1538-7445.Am2011-239  0.326
2010 O'Day CL, Ovechkina Y, Marcoe K, Keyser R, Yoshino K, Nguyen P, Bernards K, Shively R, Hnilo J, Mulligan J, Lin T, Wang S. Abstract 3590: Profiles of contributing genes to sensitive/resistant phenotypes of 11 different oncology therapeutic agents across 240 cell lines Cancer Research. 70: 3590-3590. DOI: 10.1158/1538-7445.Am10-3590  0.34
2010 O'Day C, Ovechkina Y, Marcoe K, Keyser R, Yoshino K, Nguyen P, Hnilo J, Shively R, Mulligan J, Bernards K, Lin T, Wang S, Sadis S, Rhodes DR, Warrior W. Abstract B35: High-throughput cell line profiling for identification of anticancer drug sensitivity and resistance biomarkers with OncoPredictor Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcmusa10-B35  0.323
2010 Marcoe K, Ovechkina Y, Keyser R, Bernards K, Chestnut-Speelman J, Yoshino K, O'Day C. Abstract P6-14-17:In VitroEvaluation of the Anti-EGFR Antibody Cetuximab and the Anti-HER2 Antibody Trastuzumab in a Panel of Human Tumor Cell Lines Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P6-14-17  0.314
2006 Moores CA, Cooper J, Wagenbach M, Ovechkina Y, Wordeman L, Milligan RA. The role of the kinesin-13 neck in microtubule depolymerization. Cell Cycle (Georgetown, Tex.). 5: 1812-5. PMID 16929184 DOI: 10.4161/Cc.5.16.3134  0.675
2005 Moore AT, Rankin KE, von Dassow G, Peris L, Wagenbach M, Ovechkina Y, Andrieux A, Job D, Wordeman L. MCAK associates with the tips of polymerizing microtubules. The Journal of Cell Biology. 169: 391-7. PMID 15883193 DOI: 10.1083/Jcb.200411089  0.586
2004 Newton CN, Wagenbach M, Ovechkina Y, Wordeman L, Wilson L. MCAK, a Kin I kinesin, increases the catastrophe frequency of steady-state HeLa cell microtubules in an ATP-dependent manner in vitro. Febs Letters. 572: 80-4. PMID 15304328 DOI: 10.1016/J.Febslet.2004.06.093  0.678
2004 Andrews PD, Ovechkina Y, Morrice N, Wagenbach M, Duncan K, Wordeman L, Swedlow JR. Aurora B regulates MCAK at the mitotic centromere. Developmental Cell. 6: 253-68. PMID 14960279 DOI: 10.1016/S1534-5807(04)00025-5  0.627
2003 Ovechkina Y, Maddox P, Oakley CE, Xiang X, Osmani SA, Salmon ED, Oakley BR. Spindle formation in Aspergillus is coupled to tubulin movement into the nucleus. Molecular Biology of the Cell. 14: 2192-200. PMID 12802085 DOI: 10.1091/Mbc.E02-10-0641  0.403
2003 Ovechkina Y, Wordeman L. Unconventional motoring: an overview of the Kin C and Kin I kinesins. Traffic (Copenhagen, Denmark). 4: 367-75. PMID 12753646 DOI: 10.1034/J.1600-0854.2003.00099.X  0.652
2002 Ovechkina Y, Wagenbach M, Wordeman L. K-loop insertion restores microtubule depolymerizing activity of a "neckless" MCAK mutant. The Journal of Cell Biology. 159: 557-62. PMID 12446739 DOI: 10.1083/Jcb.200205089  0.653
1999 Ovechkina YY, Pettit RK, Cichacz ZA, Pettit GR, Oakley BR. Unusual antimicrotubule activity of the antifungal agent spongistatin 1. Antimicrobial Agents and Chemotherapy. 43: 1993-9. PMID 10428925 DOI: 10.1128/Aac.43.8.1993  0.488
1999 Ovechkina YY, Pettit RK, Cichacz ZA, Pettit GR, Oakley BR. Unusual Antimicrotubule Activity of the Antifungal Agent Spongistatin 1 Antimicrobial Agents and Chemotherapy. 43: 1993-1999. DOI: 10.1128/AAC.43.8.1993  0.394
Show low-probability matches.